Key facts
| Price (PPV) | 43.80 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | carvédilol |
| Class | Beta blocking agents |
| ATC code | C07AG02 |
| Manufacturer | ATLAS PHARM |
| Presentation | Boîte de 30 |
| Nature | Médicament |
| Hospital price | 27.40 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'insuffisance cardiaque chronique stable, légère, modérée et sévère (fraction d'éjection ≤ 35%), en association avec le traitement conventionnel comportant inhibiteur de l'enzyme de conversion, diurétique et, le plus souvent, digitalique. - Dans un programme d'études cliniques, chez des patients en insuffisance cardiaque légère à modérée, le carvédilol a permis de réduire la mortalité à 6 mois de 50%, IC 95% [33% - 75%]. - Dans l'étude COPERNICUS menée chez des patients en insuffisance cardiaque sévère non décompensée, le carvédilol a permis de réduire la mortalité à 1 an de 35%, IC 95% [19% - 48%].
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Cardix 6.25 mg (PHI) contains the same active substance as Coronat 6.25 mg (Carvédilol) at the same strength, but in a different pack: Boîte de 28 at 41.90 MAD, i.e. 1.50 MAD per unit against 1.46 MAD for Coronat 6.25 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Cardinor 6.25 mg | COOPER PHARMA | Boîte de 30 | 43.80 MAD | 1.46 / unit | — |
| Celeno 6.25 mg | PHARMIS | Boite de 30 | 43.80 MAD | 1.46 / unit | — |
| Xedilol 6.25 mg | SOTHEMA | Boîte de 30 | 43.80 MAD | 1.46 / unit | — |
| Dilatrend 6.25 mg | BOTTU S.A. | Boîte de 30 | 71.10 MAD | 2.37 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Cardix 6.25 mg | PHI | Boîte de 28 | 41.90 MAD | 1.50 / unit |
| Cardinor 6.25 mg | COOPER PHARMA | Boîte de 60 | 85.70 MAD | 1.43 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Coronat 6.25 mg
Coronat 6.25 mg belongs to the beta blocking agents therapeutic class. In Morocco, this drug is marketed by ATLAS PHARM and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Coronat 6.25 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Coronat 6.25 mg
Answers to common questions from Moroccan patients about this drug.